Biological age decreased significantly! The results of anti-aging NMN human clinical trial in China's first top-level hospital jointly studied by Haven Biology, the Chinese Academy of Sciences and Shanghai Changzheng Hospital were released!
On the morning of April 27, the Lezhen Vascular Forum and the Spring Academic Forum of the Vascular Medicine Special Committee of the Chinese Pathophysiological Society were held in Shanghai. Professor Qulefeng, chairman of the conference, the first person in China's vascular surgery and the first postdoctoral fellow in China's vascular surgery department, released the results of the double-blind, randomized controlled clinical trial of anti-aging NMN conducted by the first top-level hospital in China jointly studied by Haven Biology, the Chinese Academy of Sciences and Shanghai Changzheng Hospital: Compared with placebo, the physiological age of the NMN supplement group was significantly reduced!
This NMN clinical trial is a randomized, double-blind, placebo-controlled phase II clinical study, which is the first NMN human clinical trial conducted in a third-class hospital in China, marking that China's research on NMN has officially entered the clinical evidence-based stage. Randomized double-blind controlled trials were conducted before and after NMN administration to analyze the effects of NMN on human aging markers, and to record the regulation of transcription levels of genes related to aging, cell cycle, and disease. The test results showed that after taking NMN (300mg/day) for 60 days, the level of NMN downstream age-related metabolites in blood was significantly increased, and the physiological age was significantly decreased! 40% of subjects indicated that sleep quality was improved after taking NMN, 30% indicated that appetite was increased after taking NMN, 55% indicated that motor function was improved after taking NMN, 70% indicated that daily fatigue was reduced after taking NMN, 60% indicated that daily blood pressure monitoring level was decreased after taking NMN, and 45% indicated that taking NMN After blood glucose monitoring levels drop.
The 99.99% ultra-high purity NMN used in this experiment is from Haven biology. In the future, Haven Biology will continue to uphold the original mission of "creating beauty and health with biotechnology", further deepen cooperation and exchanges with the academic community, jointly promote basic research related to NMN, provide strong scientific theoretical support for the long-term development of the industry, and contribute to the promotion of global life health!